Education
About Us
Working with TipRanks
Follow Us
Shanghai Heartcare Medical Technology Corp. Ltd. Class H (HK:6609)
:6609
Total Valuation
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has a market cap or net worth of HK$2.15B. The enterprise value is HK$745.26M.
Market CapHK$2.15B
Enterprise ValueHK$745.26M
Share Statistics
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has 31,565,804 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,565,804
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -0.63%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)-0.63%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee807.85K
Profits Per Employee-34.86K
Employee Count344
Asset Turnover0.23
Inventory Turnover0.56
Valuation Ratios
The current PE Ratio of Shanghai Heartcare Medical Technology Corp. Ltd. Class H is 46.1. Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s PEG ratio is 0.67.
PE Ratio46.1
PS Ratio2.80
PB Ratio0.73
Price to Fair Value0.73
Price to FCF-92.80
Price to Operating Cash Flow261.55
PEG Ratio0.67
Income Statement
In the last 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H had revenue of 277.90M and earned -13.62M in profits. Earnings per share was -0.36.
Revenue277.90M
Gross Profit181.72M
Operating Income-6.24M
Pretax Income-11.99M
Net Income-13.62M
EBITDA21.87M
Earnings Per Share (EPS)-0.36
Cash Flow
In the last 12 months, operating cash flow was 41.60M and capital expenditures -11.05M, giving a free cash flow of 30.56M billion.
Operating Cash Flow41.60M
Free Cash Flow30.56M
Free Cash Flow per Share0.97
Dividends & Yields
Shanghai Heartcare Medical Technology Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.30
52-Week Price Change159.86%
50-Day Moving Average60.24
200-Day Moving Average38.72
Relative Strength Index (RSI)35.65
Average Volume (3m)127.28K
Important Dates
Shanghai Heartcare Medical Technology Corp. Ltd. Class H upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Shanghai Heartcare Medical Technology Corp. Ltd. Class H as a current ratio of 12.42, with Debt / Equity ratio of 3.37%
Current Ratio12.42
Quick Ratio10.34
Debt to Market Cap0.00
Net Debt to EBITDA-25.89
Interest Coverage Ratio-3.57
Taxes
In the past 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H has paid 1.63M in taxes.
Income Tax1.63M
Effective Tax Rate-0.14
Enterprise Valuation
Shanghai Heartcare Medical Technology Corp. Ltd. Class H EV to EBITDA ratio is 9.72, with an EV/FCF ratio of -25.32.
EV to Sales0.76
EV to EBITDA9.72
EV to Free Cash Flow-25.32
EV to Operating Cash Flow-65.69
Balance Sheet
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has HK$718.20M in cash and marketable securities with HK$35.75M in debt, giving a net cash position of HK$672.29M billion.
Cash & Marketable SecuritiesHK$718.20M
Total DebtHK$35.75M
Net CashHK$672.29M
Net Cash Per ShareHK$21.30
Tangible Book Value Per ShareHK$26.98
Margins
Gross margin is 65.39%, with operating margin of -2.24%, and net profit margin of -4.90%.
Gross Margin65.39%
Operating Margin-2.24%
Pretax Margin-4.32%
Net Profit Margin-4.90%
EBITDA Margin7.87%
EBIT Margin-3.69%
Analyst Forecast
The average price target for Shanghai Heartcare Medical Technology Corp. Ltd. Class H is HK$61.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$61.00
Price Target Upside10.21% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast32.93%
EPS Growth Forecast―